Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Llovet, Josep"" wg kryterium: Autor


Tytuł:
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy
Autorzy:
Tanabe, Kenneth K.
Zahrieh, David
Strand, Carrie A.
Hoshida, Yujin
Flotte, Thomas J.
Della’Zanna, Gary
Umar, Asad
Chavin, Kenneth D.
Cleary, Sean
Kubota, Naoto
Llovet, Josep M.
Patel, Tushar
Siegel, Christopher
Limburg, Paul J.
Pokaż więcej
Źródło:
In Gastro Hep Advances 2024 3(3):426-439
Czasopismo naukowe
Tytuł:
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Autorzy:
Strasser, Simone
Thompson, Alexander
Roohullah, Aflah
Sievert, William
Andelkovic, Vladimir
Knox, Jennifer
Davies, Janine
Asselah, Jamil
Brahmania, Mayur
Majeed, Habeeb
Villanueva, Luis
Yanez Weber, Patricio
Garrido, Marcelo
Pizarro, Gonzalo Ignacio
Yanez, Nicolas
Xu, Ruocai
Ou, Shuangyan
Ren, Zhenggang
Pan, Hongming
Meng, Zhiqiang
Gu, Kangsheng
Chen, Xi
Zhang, Tao
Hao, Chunyi
Cao, Peiguo
Guo, Yabing
Qin, Shukui
Xiao, Juxiang
Fang, Weijia
Wang, Xin
Bai, Yuxian
Chen, Xiaoming
Yan, Dong
Zhao, Hong
Ying, Jieer
Bonilla, Carlos
Urrego, Olga
Zambrano, Angela
Lema, Mauricio
Restrepo Gutierrez, Juan Carlos
Cardona, Andres
Franco Millan, Sandra
Oscar, Madiedo
Ramos, Victor
Merle, Philippe
LeSourd, Samuel
Edeline, Julien
Bronowicki, Jean-Pierre
Bourliere, Marc
Cattan, Stephane
Bouattour, Mohamed
Mineur, Laurent
Regnault, Helene
Dauvois, Barbara
Schulze, Kornelius
Folprecht, Gunnar
Geier, Andreas
Waidmann, Oliver
Finkelmeier, Fabian
Venerito, Marino
Berres, Marie-Luise
Berg, Thomas
Lange, Christian
Schmidt, Hartmut
Waldschmidt, Dirk T
Bitzer, Michael
McDermott, Ray
Duffy, Austin
Masi, Gianluca
Zagonel, Vittorina
Tonini, Giuseppe
Piscaglia, Fabio
Gori, Stefania
Rizzo, Mimma
Biscaldi, Elisa
Foltran, Luisa
Cabibbo, Giuseppe
Ikeda, Masafumi
Kudo, Masatoshi
Aikata, Hiroshi
Numata, Kazushi
Marusawa, Hiroyuki
Kato, Naoya
Kurosaki, Masayuki
Morimoto, Manabu
Yamashita, Tatsuya
Koga, Hironori
Masaki, Tsutomu
Tateishi, Ryosuke
Inaba, Yoshitaka
Arakawa, Tomohiro
Suzuki, Yoshiyuki
Akua, Norio
Kobayashi, Masahiro
Hosaka, Tetsuya
Nakamuta, Makoto
Oza, Noriko
Kondo, Shunsuke
Furuse, Junji
Nagashima, Fumio
Kitano, Masayuki
Takaguchi, Koichi
Ryoo, Baek-Yeol
Lim, Ho Yeong
Kim, Jee Hyun
Kim, Tae-You
Kim, Han Sang
Hernandez Hernandez, Carlos
Motola Kuba, Daniel
Segura Gonzalez, Manuel
Cabrera Luviano, Jesus
Huitzil Melendez, Fidel
Ramirez Godinez, Francisco
Silva-Bravo, Fernando
Gane, Edward
Stedman, Catherine
Kwiatkowski, Mariusz
Wyrwicz, Lucjan
Nowakowska-Zajdel, Ewa
Kraj, Leszek
Janczewska, Ewa
Surma-Wlodarczyk, Renata
Breder, Valeriy
Sekacheva, Marina
Orlova, Rashida
Vasilyev, Alexander
Zukov, Ruslan
Vladimirov, Vladimir
Minguez, Beatriz
Matilla Pena, Ana
Fernandez Castroagudin, Javier
Romero Gomez, Manuel
Luis Lledo, Jose
Rubin, Angel
Garcia Sanchez, Araceli
Calleja Panero, Jose
Yu, Ming-Chin
Shen, Ying-Chun
Huang, Yi-Hsiang
Jeng, Long-Bin
Chang, Ting-Tsung
Yang, Sheng-Shun
Chen, Shinn-Cherng
Dechaphunkul, Arunee
Tanwandee, Tawesak
Leerapun, Apinya
Seker, Mesut
Harputluoglu, Hakan
Cicin, Irfan
Oksuzoglu, Berna
Bilici, Mehmet
Sezgin Goksu, Sema
Artac, Mehmet
Cil, Timucin
Yalcin, Suayib
Meyer, Tim
Sarker, Debashis
Rao, Ankit
Palmer, Daniel
Evans, Jeff
Hubner, Richard
Finn, Richard
Ulahannan, Susanna
Zakari, Ahmed
Feun, Lynn
Al-Rajabi, Raed
Sung, Max
He, Aiwu
Kardosh, Adel
Goyal, Lipika
Li, Daneng
Choi, Minsig
Posada, Juan
Dodlapati, Jyothi
Shroff, Rachna
Agrawal, Saurabh
Gopaluni, Srivalli
Akce, Mehmet
Alese, Olatunji
Baron, Ari
Dunne, Richard
Loaiza-Bonilla, Arturo
Frenette, Catherine
Llovet, Josep M
Kumada, Hiromitsu
Cheng, Ann-Lii
Galle, Peter R
Kaneko, Shuichi
Wang, Anran
Mody, Kalgi
Dutcus, Corina
Dubrovsky, Leonid
Siegel, Abby B
Finn, Richard S
Pokaż więcej
Źródło:
In The Lancet Oncology December 2023 24(12):1399-1410
Czasopismo naukowe
Tytuł:
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer
Autorzy:
Ortiz-Barahona, Vanessa
Soler, Marta
Davalos, Veronica
García-Prieto, Carlos A.Aff1, Aff2
Janin, Maxime
Setien, Fernando
Fernández-Rebollo, Irene
Bech-Serra, Joan J.
De La Torre, Carolina
Guil, SoniaAff4, Aff5
Villanueva, Alberto
Zhang, Pei-HongAff7, Aff8
Yang, Li
Guarnacci, Marco
Schumann, Ulrike
Preiss, ThomasAff9, Aff10
Balaseviciute, Ugne
Montal, Robert
Llovet, Josep M.Aff11, Aff13, Aff14
Esteller, ManelAff1, Aff14, Aff15, Aff16, IDs1294302301785z_cor20
Pokaż więcej
Źródło:
Molecular Cancer. 22(1)
Czasopismo naukowe
Tytuł:
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment
Autorzy:
Llovet, Josep M.Aff1, Aff2, Aff3, IDs00270021030319_cor1
Vogel, Arndt
Madoff, David C.
Finn, Richard S.
Ogasawara, Sadahisa
Ren, Zhenggang
Mody, Kalgi
Li, Jerry J.
Siegel, Abby B.
Dubrovsky, Leonid
Kudo, Masatoshi
Pokaż więcej
Źródło:
CardioVascular and Interventional Radiology. 45(4):405-412
Czasopismo naukowe
Tytuł:
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials
Autorzy:
Zhu, Andrew X.
Nipp, Ryan D.
Finn, Richard S.
Galle, Peter R.
Llovet, Josep M.
Blanc, Jean-Frederic
Okusaka, Takuji
Chau, Ian
Cella, David
Girvan, Allicia
Gable, Jonathon
Bowman, Lee
Wang, Chunxiao
Hsu, Yanzhi
Abada, Paolo B.
Kudo, Masatoshi
Pokaż więcej
Źródło:
In ESMO Open 2020 5(4)
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Autorzy:
Zhu, Andrew X
Kang, Yoon-Koo
Yen, Chia-Jui
Finn, Richard S
Galle, Peter R
Llovet, Josep M
Assenat, Eric
Brandi, Giovanni
Pracht, Marc
Lim, Ho Yeong
Rau, Kun-Ming
Motomura, Kenta
Ohno, Izumi
Merle, Philippe
Daniele, Bruno
Shin, Dong Bok
Gerken, Guido
Borg, Christophe
Hiriart, Jean-Baptiste
Okusaka, Takuji
Morimoto, Manabu
Hsu, Yanzhi
Abada, Paolo B
Kudo, Masatoshi
Pokaż więcej
Źródło:
In The Lancet Oncology February 2019 20(2):282-296
Czasopismo naukowe
Tytuł:
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Autorzy:
Pfister, DominikAff1, Aff82
Núñez, Nicolás Gonzalo
Pinyol, Roser
Govaere, Olivier
Pinter, MatthiasAff5, Aff6
Szydlowska, Marta
Gupta, RevantAff7, Aff8
Qiu, Mengjie
Deczkowska, Aleksandra
Weiner, Assaf
Müller, Florian
Sinha, AnkitAff11, Aff12
Friebel, Ekaterina
Engleitner, ThomasAff13, Aff14, Aff15
Lenggenhager, Daniela
Moncsek, Anja
Heide, Danijela
Stirm, Kristin
Kosla, Jan
Kotsiliti, Eleni
Leone, ValentinaAff1, Aff18
Dudek, Michael
Yousuf, Suhail
Inverso, DonatoAff20, Aff21
Singh, IndrabahadurAff1, Aff22
Teijeiro, Ana
Castet, Florian
Montironi, Carla
Haber, Philipp K.
Tiniakos, DinaAff4, Aff25
Bedossa, Pierre
Cockell, Simon
Younes, RamyAff4, Aff27
Vacca, Michele
Marra, Fabio
Schattenberg, Jörn M.
Allison, Michael
Bugianesi, Elisabetta
Ratziu, Vlad
Pressiani, Tiziana
D’Alessio, Antonio
Personeni, NicolaAff33, Aff34
Rimassa, LorenzaAff33, Aff34
Daly, Ann K.
Scheiner, BernhardAff5, Aff6
Pomej, KatharinaAff5, Aff6
Kirstein, Martha M.Aff35, Aff36
Vogel, Arndt
Peck-Radosavljevic, Markus
Hucke, Florian
Finkelmeier, Fabian
Waidmann, Oliver
Trojan, Jörg
Schulze, Kornelius
Wege, Henning
Koch, Sandra
Weinmann, Arndt
Bueter, Marco
Rössler, Fabian
Siebenhüner, Alexander
De Dosso, Sara
Mallm, Jan-Philipp
Umansky, ViktorAff45, Aff46
Jugold, Manfred
Luedde, Tom
Schietinger, AndreaAff49, Aff50
Schirmacher, Peter
Emu, Brinda
Augustin, Hellmut G.Aff20, Aff21
Billeter, Adrian
Müller-Stich, Beat
Kikuchi, Hiroto
Duda, Dan G.
Kütting, Fabian
Waldschmidt, Dirk-Thomas
Ebert, Matthias Philip
Rahbari, Nuh
Mei, Henrik E.
Schulz, Axel Ronald
Ringelhan, MarcAff58, Aff59, Aff60
Malek, Nisar
Spahn, Stephan
Bitzer, Michael
Ruiz de Galarreta, MarinaAff24, Aff62
Lujambio, AmaiaAff24, Aff62, Aff63
Dufour, Jean-FrancoisAff64, Aff65
Marron, Thomas U.Aff24, Aff66
Kaseb, Ahmed
Kudo, Masatoshi
Huang, Yi-HsiangAff69, Aff70
Djouder, Nabil
Wolter, KatharinaAff71, Aff72
Zender, LarsAff71, Aff72, Aff73
Marche, Parice N.Aff74, Aff75
Decaens, ThomasAff74, Aff75, Aff76
Pinato, David J.Aff77, Aff78
Rad, RolandAff13, Aff14, Aff15
Mertens, Joachim C.
Weber, AchimAff16, Aff79
Unger, Kristian
Meissner, Felix
Roth, Susanne
Jilkova, Zuzana MacekAff74, Aff75, Aff77
Claassen, ManfredAff7, Aff8
Anstee, Quentin M.Aff4, Aff80
Amit, Ido
Knolle, Percy
Becher, Burkhard
Llovet, Josep M.Aff3, Aff24, Aff81
Heikenwalder, Mathias
Pokaż więcej
Źródło:
Nature: International weekly journal of science. 592(7854):450-456
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
Autorzy:
Miltiadous, Oriana
Sia, Daniela
Hoshida, Yujin
Fiel, Maria Isabel
Harrington, Andrew N.
Thung, Swan N.
Tan, Poh Seng
Dong, Hui
Revill, Kate
Chang, Charissa Y.
Roayaie, Sasan
Byrne, Thomas J.
Mazzaferro, Vincenzo
Rakela, Jorge
Florman, Sander
Schwartz, Myron
Llovet, Josep M.
Pokaż więcej
Źródło:
In Journal of Hepatology December 2015 63(6):1368-1377
Czasopismo naukowe
Tytuł:
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Autorzy:
Bruix, Jordi
Takayama, Tadatoshi
Mazzaferro, Vincenzo
Chau, Gar-Yang
Yang, Jiamei
Kudo, Masatoshi
Cai, Jianqiang
Poon, Ronnie T
Han, Kwang-Hyub
Tak, Won Young
Lee, Han Chu
Song, Tianqiang
Roayaie, Sasan
Bolondi, Luigi
Lee, Kwan Sik
Makuuchi, Masatoshi
Souza, Fabricio
Berre, Marie-Aude Le
Meinhardt, Gerold
Llovet, Josep M
Pokaż więcej
Źródło:
In The Lancet Oncology October 2015 16(13):1344-1354
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies